ArticleCell death & disease2018
PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer.
Qiang Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
99 papers cite itlatest 60 shown
this papercites it